Computed tomography and [

Medical imaging Medical microbiology Virology

Journal

iScience
ISSN: 2589-0042
Titre abrégé: iScience
Pays: United States
ID NLM: 101724038

Informations de publication

Date de publication:
15 Apr 2022
Historique:
received: 17 11 2021
revised: 07 03 2022
accepted: 15 03 2022
pubmed: 23 3 2022
medline: 23 3 2022
entrez: 22 3 2022
Statut: ppublish

Résumé

Non-human primates (NHPs) are particularly relevant as preclinical models for SARS-CoV-2 infection and nuclear imaging may represent a valuable tool for monitoring infection in this species. We investigated the benefit of computed X-ray tomography (CT) and [

Identifiants

pubmed: 35313622
doi: 10.1016/j.isci.2022.104101
pii: S2589-0042(22)00371-6
pmc: PMC8926429
doi:

Types de publication

Journal Article

Langues

eng

Pagination

104101

Informations de copyright

© 2022 The Author(s).

Déclaration de conflit d'intérêts

No potential conflicts of interest relevant to this article exist.

Références

Proc Natl Acad Sci U S A. 1996 Jun 25;93(13):6425-30
pubmed: 8692831
Nat Microbiol. 2021 Jan;6(1):73-86
pubmed: 33340034
Eur J Nucl Med Mol Imaging. 2020 Jun;47(6):1348
pubmed: 32166511
PLoS Pathog. 2020 Sep 18;16(9):e1008903
pubmed: 32946524
Eur J Nucl Med Mol Imaging. 2020 Jul;47(7):1634-1635
pubmed: 32198615
Int J Infect Dis. 2020 Apr;93:192-197
pubmed: 32112966
Front Med (Lausanne). 2020 Dec 03;7:594495
pubmed: 33344479
J Infect. 2020 Jul;81(1):147-178
pubmed: 32277968
Ann Intern Med. 2021 May;174(5):655-662
pubmed: 33481642
Cell. 2021 Mar 4;184(5):1188-1200.e19
pubmed: 33577765
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
Nat Immunol. 2021 Jan;22(1):86-98
pubmed: 33235385
Nature. 2020 Oct;586(7830):509-515
pubmed: 32967005
Glob Health Med. 2020 Aug 31;2(4):221-226
pubmed: 33330811
Eur J Nucl Med Mol Imaging. 2020 Jul;47(7):1649-1656
pubmed: 32342191
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
Lancet Infect Dis. 2020 Apr;20(4):425-434
pubmed: 32105637
Nat Commun. 2021 Feb 24;12(1):1260
pubmed: 33627662
Mol Immunol. 2021 Jul;135:147-164
pubmed: 33895579
Med Image Anal. 2021 Jan;67:101860
pubmed: 33171345
Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):260-268
pubmed: 32712702
Eur J Radiol. 2020 May;126:108961
pubmed: 32229322
Science. 2020 May 29;368(6494):1012-1015
pubmed: 32303590
Radiology. 2020 Aug;296(2):E15-E25
pubmed: 32083985
Cell Host Microbe. 2021 Sep 8;29(9):1437-1453.e8
pubmed: 34428428
Commun Biol. 2020 Oct 27;3(1):641
pubmed: 33110195
Nature. 2020 Sep;585(7826):584-587
pubmed: 32698191
Nature. 2021 Apr;592(7853):283-289
pubmed: 33524990
Radiology. 2020 Aug;296(2):E32-E40
pubmed: 32101510
Nat Commun. 2021 Oct 20;12(1):6097
pubmed: 34671037
Proc Natl Acad Sci U S A. 2021 Oct 26;118(43):
pubmed: 34625475
Nature. 2020 Sep;585(7824):268-272
pubmed: 32396922
J Digit Imaging. 2013 Jun;26(3):483-95
pubmed: 23053904
Radiology. 2020 Jun;295(3):715-721
pubmed: 32053470
Nature. 2020 Sep;585(7824):273-276
pubmed: 32516797

Auteurs

Thibaut Naninck (T)

Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, Paris, France.

Nidhal Kahlaoui (N)

Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, Paris, France.

Julien Lemaitre (J)

Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, Paris, France.

Pauline Maisonnasse (P)

Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, Paris, France.

Antoine De Mori (A)

Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, Paris, France.

Quentin Pascal (Q)

Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, Paris, France.

Vanessa Contreras (V)

Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, Paris, France.

Romain Marlin (R)

Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, Paris, France.

Francis Relouzat (F)

Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, Paris, France.

Benoît Delache (B)

Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, Paris, France.

Cécile Hérate (C)

Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, Paris, France.

Yoann Aldon (Y)

Departments of Medical Microbiology of the Amsterdam UMC, Amsterdam Institute for Infection and Immunity, University of Amsterdam, 1105 Amsterdam, the Netherlands.

Marit van Gils (M)

Departments of Medical Microbiology of the Amsterdam UMC, Amsterdam Institute for Infection and Immunity, University of Amsterdam, 1105 Amsterdam, the Netherlands.

Nerea Zabaleta (N)

Grousbeck Gene Therapy Center, Schepens Eye Research Institute, Mass Eye and Ear, Boston, MA 02114, USA.
Ocular Genomics Institute, Department of Ophthalmology, Harvard Medical School, Boston, MA 02115, USA.
The Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.
Harvard Stem Cell Institute, Harvard University, Cambridge, MA 02138, USA.

Raphaël Ho Tsong Fang (R)

Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, Paris, France.

Nathalie Bosquet (N)

Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, Paris, France.

Rogier W Sanders (RW)

Departments of Medical Microbiology of the Amsterdam UMC, Amsterdam Institute for Infection and Immunity, University of Amsterdam, 1105 Amsterdam, the Netherlands.
Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, NY 10021, USA.

Luk H Vandenberghe (LH)

Grousbeck Gene Therapy Center, Schepens Eye Research Institute, Mass Eye and Ear, Boston, MA 02114, USA.
Ocular Genomics Institute, Department of Ophthalmology, Harvard Medical School, Boston, MA 02115, USA.
The Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.
Harvard Stem Cell Institute, Harvard University, Cambridge, MA 02138, USA.

Catherine Chapon (C)

Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, Paris, France.

Roger Le Grand (R)

Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, Paris, France.

Classifications MeSH